Rezvoglar (
insulin glargine-aglr) is a long-acting type of insulin used to treat type 1 and
type 2 diabetes. Rezvoglar is a biosimilar for
lantus (
insulin glargine). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Rezvoglar may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost. With the Patient Assistance Program from Sanofi, you can receive your medication at no cost.